Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey S Gottlieb

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2023
Dolutegravir-based Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 (HIV-2) Infection: Progress for People With HIV-2Geoffrey S Gottlieb
AIDS (London, England)|December 11, 2012
Changing HIV epidemics: what HIV-2 can teach us about ending HIV-1Geoffrey S Gottlieb
Lancet (London, England)|June 7, 2005
Multidrug-resistant, dual-tropic HIV-1 and rapid progressionGeoffrey S Gottlieb, David C Nickle
Journal of Clinical Microbiology|December 24, 2013
A 58-year-old immunosuppressed male with chronic cough, diarrhea, and a new "pressure" ulcerBen A Zaniello, Geoffrey S Gottlieb
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2003
Unusual appendicitisGeoffrey S Gottlieb, Anna Wald, Nick Agoff
JAMA|October 28, 2010
Long-term nonprogressive disease among individuals with untreated HIV infectionGeoffrey S Gottlieb, Robert A Smith, Papa Salif Sow
Retrovirology|September 3, 2010
Susceptibility of the human retrovirus XMRV to antiretroviral inhibitorsRobert A Smith, Geoffrey S Gottlieb, A Dusty Miller
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2009
Strongyloidiasis in transplant patientsAlison C Roxby, Geoffrey S Gottlieb, Ajit P Limaye
Journal of Virology|November 13, 2015
Four Amino Acid Changes in HIV-2 Protease Confer Class-Wide Sensitivity to Protease InhibitorsDana N Raugi, Robert A Smith, Geoffrey S Gottlieb, et al.
The Lancet. HIV|July 28, 2018
90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2Geoffrey S Gottlieb, Dana N Raugi, Robert A Smith
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2023
Dolutegravir-based Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 (HIV-2) Infection: Progress for People With HIV-2Geoffrey S Gottlieb
AIDS (London, England)|December 11, 2012
Changing HIV epidemics: what HIV-2 can teach us about ending HIV-1Geoffrey S Gottlieb
Lancet (London, England)|June 7, 2005
Multidrug-resistant, dual-tropic HIV-1 and rapid progressionGeoffrey S Gottlieb, David C Nickle
Journal of Clinical Microbiology|December 24, 2013
A 58-year-old immunosuppressed male with chronic cough, diarrhea, and a new "pressure" ulcerBen A Zaniello, Geoffrey S Gottlieb
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2003
Unusual appendicitisGeoffrey S Gottlieb, Anna Wald, Nick Agoff
JAMA|October 28, 2010
Long-term nonprogressive disease among individuals with untreated HIV infectionGeoffrey S Gottlieb, Robert A Smith, Papa Salif Sow
Retrovirology|September 3, 2010
Susceptibility of the human retrovirus XMRV to antiretroviral inhibitorsRobert A Smith, Geoffrey S Gottlieb, A Dusty Miller
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2009
Strongyloidiasis in transplant patientsAlison C Roxby, Geoffrey S Gottlieb, Ajit P Limaye
Journal of Virology|November 13, 2015
Four Amino Acid Changes in HIV-2 Protease Confer Class-Wide Sensitivity to Protease InhibitorsDana N Raugi, Robert A Smith, Geoffrey S Gottlieb, et al.
The Lancet. HIV|July 28, 2018
90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2Geoffrey S Gottlieb, Dana N Raugi, Robert A Smith
Pageof 12